email address: Career Summary: Having spent over eleven years entrusted as the sole Clinical Research Coordinat

or and Manager of a large Neurology practice I have developed strong skills in t he field of Clinical Research. With my enthusiasm to reach high goals, I pursued not only being chosen to perform trials at the site, but to bring large numbers of qualified subjects in our office. Sound communication and a thorough histori cal inquiry with subjects limited screen failures, and produced completed subjec t statuses time and time again. By maintaining a high respect for quality, accur acy of details, and deadline achievement, I am seen as someone who takes the job seriously. I have exceptional ability to promptly resolve concerns or inquiries . My personal target is a position within a pharmaceutical or biotechnology compan y, or their affiliates. I seek to work with an organization which utilizes my qu alifications and enhances both the organization's goals and my own. Professional Experience: Clinical Research Coordinator & Manager Northridge Neurological Research, Northridge, CA I managed Phase I-IV trials from start-up to archival processes. September 1999-December 2010 Home Health Nurse Mid Valley Nursing Registry, Van Nuys, CA I provided professional and thoughtful private home care for complexly-involved pediatric and adolescent patients, as well adult and geriatric populations. November 1982-June 1983 Floor nurse and team leader Northridge Hospital Medical Center, Northridge, CA I was responsible for dispensing medication, diabetic teaching, nursing assistan t oversight, and direct patient care. May 1980-November 1982 Key Achievements: *Researched and presented study findings at Nurse Practitioner conventions *Managed Phase III trial audit with foreign governmental agency *Managed multi-site, 50 subject, Multiple Sclerosis trial including data capturi ng, monitoring, study start-up, randomization, enrollment, and budgeting. Study involved management of computer programming and personnel for customization of d ata entry. *Personally represented major Neurological research organization on many occasio ns *Managed several assistants Education: Abraham Friedman L.A. Paramedical (clinical setting UCLA Medical Center) Licensure:

California Licensed Vocational Nurse No. VN 100853 (current) Research Certification: ACRP (Association of Clinical Research Professionals) Certification received: April 13, 2002 Skills: *Able to work under many levels of supervision *Excellent managerial skills *Excellent organization, planning and problem-solving abilities *Excellent attention to detail, utilization of nursing background, along with an alytical skills to achieve the highest quality observation and reporting of subj ect outcomes *Established interpersonal and communication skills *Excellent computer proficiency and acquaintance with many clinical trial data e ntry systems and regulatory document submission portals (Inform, Oracle, RAVE, I ntralinks, etc.) Skills Summary: *Certified Clinical Research Coordinator and nurse with over eleven years experience in research field. *Ongoing knowledge and maintenance of Good Clinical Practices, ICH Guidelines, the Federal Code of Regulations, and IATA regulations necessary for completing Clinical Research tasks. *Always striving towards collection of timely and accurate data, with subject sa fety being paramount to implementation of each protocol. *Significant application of thorough source template creation and documentation, and protocol administration, IRB communication, and audit preparation tasks. *Excellent at clinical trial preparation, including but not limited to: contract ual agreements, budgetary processes, subject selection, education, and supervisi on. *Extensive experience in implementation of psychological scales and evaluations including but not limited to: BAC (Brief Assessment of Cognition), C-SSRS (Colum bia Suicide Severity Rating Scale), MMSE (Mini Mental State Examination) and the HAM-D (Hamilton Rating Scale for Depression) Affiliations: ACRP member Certified Clinical Research Coordinator (CCRC) Study Participation: November 2009-December 2010: Parkinson's disease, Open Label Dopamine Agonist, Phase 4 July 2009-December 2010: Partial Onset Epilepsy Study, Monotherapy, Phase 3 June 2009-October 2010: Restless Legs Study, Phase 3

June 2010: Managed and hosted Japanese PMDA Audit on Restless Legs Trial April 2010-July 2010: Fibromyalgia study, Single-blind safety and tolerability study, Phase 3 January 2010: Multiple Sclerosis dose escalation/side effect management. Expanded Study data e valuation July 2008-June 2010: Fibromyalgia study, Open-label long term safety study, Phase 3 June 2008-February 2009: Painful Diabetic Neuropathy, Phase 2B June 2008-July 2009: Post-Herpetic Neuralgia study, Phase 2B February-September 2008: Neuropathic Pain study, Phase 1 February 2008-June 2009: Fibromyalgia study, Phase 3 November 2007-June 2009: Adult Migraine study, Phase 3 October 2007-September 2008: Adolescent Migraine study, Open-Label, Phase 3 January 2007-March 2009: Restless Legs Study, Open-Label, Phase 3 January 2007-June 2009: Partial Epilepsy add on therapy study, Phase 3 November 2006-January 2008: Blood Collection Study for the Passive Transfer of Immunoglobulin G in Subjects with Autoimmune Diseases October 2006-July 2007: Blood Draw Study to Obtain Layer of Cells from Whole Blood in MS Patients August 2006-February 2008: Restless Legs study, Phase 3 November 2005-April 2007: Restless Legs study, Open-label, Phase 2 August 2005-October 2006: Migraine Study, Phase 4 July-November 2005: Diabetic Neuropathy, Phase 2 June 2005-September 2008: Partial Epilepsy add on therapy study, Phase 2

June 2005-April 2007: Painful Diabetic Neuropathy study, Phase 3 June-December 2005: Restless Legs study, Phase 2 January 2005-January 2006: Restless Legs study, Open-Label conversion to Double-blind, Phase 3 November 2004-March2005: Migraine study, Phase 3 October 2004-August 2005: Restless Legs study, Phase 3 March 2004-January 2005: Parkinson's disease study, Phase 3 October 2003-January 2006: Partial Seizures Study, Phase 3 October 2003-May 2004: Restless Legs study, Phase 3 October 2003-September 2004: Alzheimer's disease study, Phase 4 July 2003-September 2004: Painful Diabetic Neuropathy study, Phase 3 December 2002-October 2003: Painful Diabetic Neuropathy study, Phase 3 December 2002-June 2004: Restless Legs study, open-label Phase 3 March 2002-January 2005: Multiple Sclerosis Dose Escalation/ Side Effect Management study, Phase 4 January 2002-October 2003: Newly Diagnosed Complex Partial Seizure study, Phase 3 January 2002-January 2003: Uncontrolled GTC Seizure study, Phase 3 January 2002-July 2002: Restless Legs study, Phase 2 May 2001-March 200: Parkinson's disease study with and without device, Phase 4 May 2001-May 2002: Parkinson's disease study, Phase 3 May 2001-March 2002: Migraine study, Phase 4 January 2001-August 2001: Add-on partial epilepsy study, Phase 3

December 2000-November 2001: Uncontrolled epilepsy study, Phase 4 April 2000-December 2000: Statin Therapy upon High-Sensitivity C-reactive Protein, Phase 3 January 2000-January 2002: Diabetic Peripheral Neuropathy study, Phase 3 November 1999-November 2003: Newly Diagnosed and Recurrent Seizure study, Phase 3 November 1999-January 2001: Monotherapy in Epilepsy Patients with Partial Seizures, Phase 3 September 1999-January 2002: Vitamin Intervention for Stroke Prevention September 1999-May 2000: Monotherapy in Newly Diagnosed or Recurrent Generalized Epilepsy, Phase 3 September 1999-February 2000: Investigational New Drug Protocol for Stroke Recovery, Phase 3 September 1999-January 2000: Citicoline in Stroke Recovery, Interneuron Pharmaceuticals, affiliation at North ridge Hospital Medical Center Good Clinical Practice Research Training & Other Specific Skills Training: August 2010: Pfizer-sponsored online course "GCP for Investigational Site Staff" February 2010: 2009 IATA Class 6.2 Infectious Substance Shipping Training: Introduction, Univer sity of Cincinnati September 2009: "Good Clinical Practice Training for Investigators and Trial Personnel"- web bas ed training from Next Generation Clinical Research June 2009: 2009 IATA Class 6.2 Infectious Substance Shipping Training: CATEGORY B, BIOLOGIC AL SUBSTANCES - Web Course, University of Cincinnati June 2009: HIPAA Privacy Training for Researchers - Web Course, University of Cincinnati June 2009: Blood Borne Pathogens - Web Course, University of Cincinnati June 2009: 2009 Dry Ice Shipping Training, University of Cincinnati June 2009: Certified as a Rating Administrator "Columbia- Suicide Severity Rating Scale" April 2009: Certified as a Rating Administrator "Columbia- Suicide Severity Rating Scale" September 2008:

Investigator Safety Training Assessment, Johnson & Johnson Research and Developm ent, L.L.C. April 2007: GSK Pharmaceuticals sponsored online course on Placebo Response February 2007: SAF-T-PAK shipping infectious substances course September 2006: Informed Consent Processes, SAE Reporting, Pharmacogenomics, GCP compliance, tra ining courses in conjunction with Johnson & Johnson Research & Development, L.L. C. August 2006: Certified as BAC (The Brief Assessment of Cognition) rater by Richard Keefe, PhD , CEO Neurcog Trials, Inc. July 2006: GSK Pharmaceuticals sponsored online course on Diversity, Monitoring, Data Manag ement, GCP Compliance, Pharmacogenetics, and Safety Reporting September 2005: SAF-T-PAK shipping infectious substances course April 2005: GSK Pharmaceuticals sponsored online course on Diversity, Monitoring, Data Manag ement, GCP Compliance, and Safety Reporting September 2004: GSK Pharmaceuticals sponsored online course on GCP Compliance, Adverse Event Rep orting, Monitoring Procedures, and Data Management June 2004: NIH sponsored Human Participants Protection Education for Research Teams May 2003: Recertification UCLA Protection of Human Subjects May 2003: Certification UCLA HIPAA Privacy Rule Education Course February 2003: Course completion "Human Participants Protection Education for Research Teams" April 2001: UCLA Protection of Human Research Subjects Course Bibliography: "Symptom Severity, Sleep Disturbance, and Quality of Life Response in Patients w ith Restless Legs Syndrome (RLS) Treated with Ropinirole CR", Authors: L.K. Carothers, LVN, CCRC; R.B. Ziman, MD, FACP; C.K. Caivano, PharmD American Academy of Nurse Practitioners, Indianapolis, Indiana, June 2007. "Effect of Ropinirole Treatment on Aspects of Sexual Activity in Patients with R estless Legs Syndrome (RLS)" Authors: L Keating Carothers, LVN, CCRC, R B Ziman, MD, FACP, C K Caivano, Pharm D American College of Nurse Practitioners 2006 National Clinical Conference, Orlan do, Florida, October 2006. "The Role of Ropinirole in Treatment of Restless Legs Syndrome (RLS) in Patients

Who Have Failed Other Pharmacotherapies" Authors: L Keating Carothers, LVN, CCRC, R Ziman, MD, FACP, N Earl, MD American Academy of Nurse Practitioners, Lake Grapevine, Texas, June 2006.